171 related articles for article (PubMed ID: 2150406)
21. [Value of Clodronate in the treatment of bone metastasis].
Pouillart P; Beuzeboc P
Bull Cancer; 1991; 78(8):737-41. PubMed ID: 1834287
[TBL] [Abstract][Full Text] [Related]
22. The analgesic efficacy of clodronate compared with placebo in patients with painful bone metastases from prostatic cancer.
Strang P; Nilsson S; Brändstedt S; Sehlin J; Borghede G; Varenhorst E; Bandman U; Borck L; Englund G; Selin L
Anticancer Res; 1997; 17(6D):4717-21. PubMed ID: 9494595
[TBL] [Abstract][Full Text] [Related]
23. Bisphosphonates for cancer patients: why, how, and when?
Body JJ; Mancini I
Support Care Cancer; 2002 Jul; 10(5):399-407. PubMed ID: 12136223
[TBL] [Abstract][Full Text] [Related]
24. Effects of a new aminodiphosphonate (aminohydroxybutylidene diphosphonate) in patients with osteolytic lesions from metastases and myelomatosis. Comparison with dichloromethylene diphosphonate.
Attardo-Parrinello G; Merlini G; Pavesi F; Crema F; Fiorentini ML; Ascari E
Arch Intern Med; 1987 Sep; 147(9):1629-33. PubMed ID: 2957971
[TBL] [Abstract][Full Text] [Related]
25. [The role of adjuvant clodronate therapy for prevention of bone metastasis in breast cancer].
Horváth Z
Magy Onkol; 2002; 46(4):361-4. PubMed ID: 12563361
[TBL] [Abstract][Full Text] [Related]
26. Intravenous clodronate for acute pain induced by osteoporotic vertebral fracture.
Rovetta G; Monteforte P; Balestra V
Drugs Exp Clin Res; 2000; 26(1):25-30. PubMed ID: 10761534
[TBL] [Abstract][Full Text] [Related]
27. [The analgesic effect of calcitonin on breast cancer patients with bone metastases].
Kimura M; Abe R
Gan No Rinsho; 1987 Jul; 33(8):921-7. PubMed ID: 3613114
[TBL] [Abstract][Full Text] [Related]
28. Clodronate in the prevention and treatment of skeletal metastasis.
Gulley J; Dahut WL
Expert Rev Anticancer Ther; 2005 Apr; 5(2):221-30. PubMed ID: 15877520
[TBL] [Abstract][Full Text] [Related]
29. Prostate cancer and bone metastases. The effect of clodronate.
Kylmälä T
Ann Chir Gynaecol; 1998; 87(1):59-60. PubMed ID: 9598233
[No Abstract] [Full Text] [Related]
30. Effects of disodium dichloromethylene diphosphonate on hypercalcemia produced by bone metastases.
Chapuy MC; Meunier PJ; Alexandre CM; Vignon EP
J Clin Invest; 1980 May; 65(5):1243-7. PubMed ID: 6444955
[TBL] [Abstract][Full Text] [Related]
31. The use of bone markers in a 6-week study to assess the efficacy of oral clodronate in patients with metastatic bone disease.
Brown JE; McCloskey EV; Dewar JA; Body JJ; Cameron DA; Harnett AN; Ruutu M; Purohit OP; Tähtelä R; Coleman RE
Calcif Tissue Int; 2007 Nov; 81(5):341-51. PubMed ID: 17874331
[TBL] [Abstract][Full Text] [Related]
32. A randomized, controlled trial of intravenous clodronate in patients with metastatic bone disease and pain.
Ernst DS; Brasher P; Hagen N; Paterson AH; MacDonald RN; Bruera E
J Pain Symptom Manage; 1997 Jun; 13(6):319-26. PubMed ID: 9204651
[TBL] [Abstract][Full Text] [Related]
33. Role of bisphosphonates in prevention and treatment of bone metastases from breast cancer.
Paterson AH; Kanis JA; Powles TJ; McCloskey E; Hanson J; Ashley S
Can J Oncol; 1995 Dec; 5 Suppl 1():54-7. PubMed ID: 8853526
[TBL] [Abstract][Full Text] [Related]
34. Three-year oral clodronate treatment does not impair mineralization of newly formed bone--a histomorphometric study.
Saarto T; Taube T; Blomqvist C; Vehmanen L; Elomaa I
Calcif Tissue Int; 2005 Aug; 77(2):84-90. PubMed ID: 16075363
[TBL] [Abstract][Full Text] [Related]
35. Effect of oral clodronate on metastatic bone pain: a double-blind, placebo-controlled study.
Robertson AG; Reed NS; Ralston SH
J Clin Oncol; 1995 Sep; 13(9):2427-30. PubMed ID: 7666103
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetic and tolerability of i.m. disodium clodronate 200 mg/lidocaine 1%, given twice monthly, in comparison with i.m. disodium clodronate 100 mg/lidocaine 1%, given weekly, in healthy postmenopausal female patients.
Radicioni M; Cremonesi G; Baraldi E; Leuratti C; Mariotti F
Int J Clin Pharmacol Ther; 2013 Apr; 51(4):313-22. PubMed ID: 23357844
[TBL] [Abstract][Full Text] [Related]
37. Bisphosphonates in prostate carcinoma.
Adami S
Cancer; 1997 Oct; 80(8 Suppl):1674-9. PubMed ID: 9362435
[TBL] [Abstract][Full Text] [Related]
38. Clodronate : a review of its use in the prevention of bone metastases and the management of skeletal complications associated with bone metastases in patients with breast cancer.
Dando TM; Wiseman LR
Drugs Aging; 2004; 21(14):949-62. PubMed ID: 15554753
[TBL] [Abstract][Full Text] [Related]
39. [Clinical study of eel calcitonin for relief of pain from metastatic bone lesions].
Sasaki F; Uchino J; Hata Y; Sato Y; Konno T; Okuno T; Ohira S; Taguchi K; Fuzisawa J; Oku T
Gan To Kagaku Ryoho; 1991 Mar; 18(3):437-42. PubMed ID: 2003741
[TBL] [Abstract][Full Text] [Related]
40. Effect of oral clodronate on bone pain. A controlled study in patients with metastic prostatic cancer.
Elomaa I; Kylmälä T; Tammela T; Viitanen J; Ottelin J; Ruutu M; Jauhiainen K; Ala-Opas M; Roos L; Seppänen J
Int Urol Nephrol; 1992; 24(2):159-66. PubMed ID: 1385586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
